Clinical Trial Update: Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating dolutegravir/lamivudine dual therapy in ART-naive HIV-1 infected individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: Fundación Huésped | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED